HHS vs LEE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 13, 2026

HHS

50.0
AI Score
VS
HHS Wins

LEE

33.5
AI Score

Investment Advisor Scores

HHS

50score
Recommendation
HOLD

LEE

34score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric HHS LEE Winner
Forward P/E 14.2857 15.1057 HHS
PEG Ratio 1.1907 99.0419 HHS
Revenue Growth -1.7% -10.8% HHS
Earnings Growth -90.3% -38.3% LEE
Tradestie Score 50.0/100 33.5/100 HHS
Profit Margin -3.7% -1.8% LEE
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY HHS

Relative Price Performance (Last 90 Days)

HHS 1M: -5.3% · 3M: +81.2% LEE 1M: -8.1% · 3M: -14.4%

Current Technical Phase

HHS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $4.33

LEE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.2%), weak momentum, RSI 39

RSI (14): 39.4 · Price: $6.73

Fundamentals Snapshot

Metric HHS LEE
Market Cap — —
Forward P/E 4.1 15.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.1%
Gross Margin 0.2% 0.6%
Operating Margin -0.1% 0.1%
EPS -0.77 -1.25
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.